Gesynta Pharma

Stockholm, Sweden · Founded 2017 · Privately Held (backing)

Developer of a clinical-stage pharmaceutical portfolio designed to treat inflammatory diseases by inhibiting pro-inflammatory pathways. Gesynta Pharma is based in Stockholm, Sweden and was founded in 2017. Its last reported valuation was $42.8 million in Dec 2021. It has raised $77.8 million.

Last reported valuation

$42.8M

Oct 2026

Priced at

—

Total raised

$77.8M

Last round

—

How much has Gesynta Pharma raised?

$77.8Macross 0 recorded rounds

Free account

More of Gesynta Pharma with a free account

·The complete investor list: 17 names
·Watch Gesynta Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Gesynta Pharma investors

17 investors are on record for Gesynta Pharma, including Innovestor, Industrifonden, Nordic Mentor Network For Entrepreneurship and Amboy Street Ventures.

For fundraisers

Raising for a company like Gesynta Pharma?

17 investors have backed Gesynta Pharma.

See all 17 investors →

Frequently asked about Gesynta Pharma

How much has Gesynta Pharma raised?: Gesynta Pharma has raised $77.8M in total across 0 recorded funding rounds.